Iqvia debuts clinical data analytics intelligence platform

By The Science Advisory Board staff writers

April 28, 2021 -- Iqvia has debuted a clinical data analytics intelligence platform to accelerate vaccine development and drug discovery.

Iqvia's Connected Intelligence has the following features:

    • Connects data, analytics, and services to accelerate 350 ongoing studies to find COVID-19 treatments and vaccines
    • Deploys technologies to enroll participants in 60 ongoing trials in 40 countries
    • Accelerates drug discovery by connecting companies, researchers, and government agencies
    • Links real-world data and healthcare expertise to enable COVID-19 contact tracing and testing.
    COVID-19 computing consortium focusing on near-term COVID-19 therapies
    The COVID-19 High Performance Computing Consortium said that it has entered a new phase of operation focused on helping researchers identify potential...
    PerkinElmer launches free COVID-19 data dashboards
    PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

    Copyright © 2021 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter